References

Bnouham, M., A. Ziyyat, H. Mekhfi, A. Tahri and A. Legssyer, 2006. Medicinal plants with potential antidiabetic activity-A review of ten years of herbal medicine research 1990-2000. Int. J. Diabetes Metab., 14: 1-25.
Direct Link  |  

Choi, B.T. and C.S. Shin, 2003. Reduced formation of byproduct component c in acarbose fermentation by actinoplanessp: CKD485-16. Biotechnol. Prog., 19: 1677-1682.
CrossRef  |  PubMed  |  Direct Link  |  

Grover, J.K., V. Vats, S.S. Rathi, R. Dawar, 2003. Tradition Indian antidiabetic plants attenuate progressive renal damage in streptozotozin induced diabetic mice. J. Ethnopharmocol, 81: 233-240.

Heiner, L., 2002. Acarbose an update of its therapeutic use in diabetes treatment. Clin. Drug Invest, 22: 141-156.

Hyun, C.G., S.Y. Kim, J.H. Hur, M.J. Seo, J.W. Suh and S.O. Kim, 2005. Molecular detection of alpha-glucosidase inhibitor-producing actinomycetes. J. Microbiol., 43: 313-318.
PubMed  |  

Lamba, H.S., C.S. Bhargava, M. Thakur, S. Bhargava, 2011. Alpha glucosidase and aldolase reductase inhibitory activity in vitro and anti diabetic activity in vivo of Tribulus terrestris L (Dunal). Int. J. Pharm. Pharm. Sci., 3: 270-271.

Morshed, M.A., A. Haque, B. Rokeya and L. Ali, 2011. Anti-hyperglycemic and lipid lowering effect of Terminalia arjuna Bark extract on Streptozotocin induced type-2 diabetic model rats. Int. J. Pharm. Pharm. Sci., 3: 449-453.
Direct Link  |  

Noor, H. and S.J. Ashcroft, 1998. Pharmacological characterisation of the antihyperglycaemic properties of Tinospora crispa extract. J. Ethnopharmacol., 62: 7-13.
PubMed  |  Direct Link  |  

Pujiyanto, S., Y. Lestari, A. Suwanto, S. Budiarti and L.K. Darusman, 2012. Alpha-glucosidase inhibitor activity and characterization of endophytic actinomycetes isolated from some Indonesian diabetic medicinal plants. Int. J. Pharm. Pharmaceut. Sci., 4: 327-333.
Direct Link  |  

Sriyapai, C., U.R. Dhumma, S. Sangwatanaroj, N. Kongkathip and S. Krittiyanunt, 2009. Hypoglycemic effect of tinospora crispa dry powder in outpatients with metabolic syndrome at king Chulalongkorn memorial hospital. J. Health Res., 23: 125-133.
Direct Link  |  

Stratmann, A., T. Mahmud, S. Lee, J. Distler, H.G. Floss and W. Piepersberg, 1999. The Acbc protein from actinoplanes species is a c7-cyclitol synthase related to 3-dehydroquinate synthases and is involved in the biosynthesis of the alpha -glucosidase inhibitor acarbose. J. Biol. Chem., 274: 10889-10896.

WHO, 2014. 10 Facts about Diabetes. World Health Organization, Geneva, Switzerland.

Wehmeier, U.F. and W. Piepersberg, 2004. Biotechnology and molecular biology of the α-glucosidase inhibitor acarbose. Appl. Microbiol. Biotechnol., 63: 613-625.
CrossRef  |  Direct Link  |  

Wild, S., G. Roglic, A. Green, R. Sicree and H. King, 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27: 1047-1053.
CrossRef  |  PubMed  |  Direct Link  |  

Zhang, C.S., M. Podeschwa, O. Block, H.J. Altenbach and W. Piepersberg et al., 2003. Identification of a 1epi valienol 7 kinase activity in the producer of acarbose, Actinoplanes sp.: SE50-110. FEBS. Lett., 540: 53-57.
CrossRef  |  PubMed  |  Direct Link  |